INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER

The glycosaminoglycan hyaluronan (HA), a major component of extracellular matrices (ECMs), and cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation, migration, and invasion, which are necessary for inflammation and cancer progression. CD44 and RHAMM (receptor o...

Full description

Bibliographic Details
Main Authors: SUNITI eMISRA, Roger R. Markwald, Vincent C. Hascall, Shibnath eGhatak
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00201/full
_version_ 1818333565369188352
author SUNITI eMISRA
Roger R. Markwald
Vincent C. Hascall
Shibnath eGhatak
author_facet SUNITI eMISRA
Roger R. Markwald
Vincent C. Hascall
Shibnath eGhatak
author_sort SUNITI eMISRA
collection DOAJ
description The glycosaminoglycan hyaluronan (HA), a major component of extracellular matrices (ECMs), and cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation, migration, and invasion, which are necessary for inflammation and cancer progression. CD44 and RHAMM (receptor of HA-mediated motility) are the two main HA receptors whose biological functions in human and murine inflammations and tumor cells have been investigated comprehensively. HA was initially considered to be only an inert component of connective tissues, but is now known as a dynamic molecule with a constant turnover in many tissues through rapid metabolism that involves HA molecules of various sizes: high molecular weight HA (HMW HA), low molecular weight HA (LMW HA), and oligosaccharides (oHA). The intracellular signaling pathways initiated by HA interactions with CD44 and RHAMM that lead to inflammatory and tumorigenic responses are complex. Interestingly, these molecules have dual functions in inflammations and tumorigenesis. For example, the presence of CD44 is involved in initiation of arthritis, while the absence of CD44 by genetic deletion in an arthritis mouse model increases rather than decreases disease severity. Similar dual functions of CD44 exist in initiation and progression of cancer. RHAMM overexpression is most commonly linked to cancer progression, whereas loss of RHAMM is associated with malignant peripheral nerve sheath tumor growth. HA may similarly perform dual functions. An abundance of HMW HA can promote malignant cell proliferation and development of cancer, whereas antagonists to HA-CD44 signaling inhibit tumor cell growth in vitro and in vivo by interfering with HMWHA-CD44 interaction. This review describes the roles of HA interactions with CD44 and RHAMM in inflammatory responses and tumor development/progression, and how therapeutic strategies that block these key inflammatory/tumorigenic processes may be developed in rodent and human diseases
first_indexed 2024-12-13T13:53:39Z
format Article
id doaj.art-edf68524a1fa4e4ba9c1a88c872ee240
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-13T13:53:39Z
publishDate 2015-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-edf68524a1fa4e4ba9c1a88c872ee2402022-12-21T23:43:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242015-05-01610.3389/fimmu.2015.00201137534INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCERSUNITI eMISRA0Roger R. Markwald1Vincent C. Hascall2Shibnath eGhatak3Medical University of South CarolinaMedical University of South CarolinaCleveland ClinicMedical University of South CarolinaThe glycosaminoglycan hyaluronan (HA), a major component of extracellular matrices (ECMs), and cell surface receptors of HA have been proposed to have pivotal roles in cell proliferation, migration, and invasion, which are necessary for inflammation and cancer progression. CD44 and RHAMM (receptor of HA-mediated motility) are the two main HA receptors whose biological functions in human and murine inflammations and tumor cells have been investigated comprehensively. HA was initially considered to be only an inert component of connective tissues, but is now known as a dynamic molecule with a constant turnover in many tissues through rapid metabolism that involves HA molecules of various sizes: high molecular weight HA (HMW HA), low molecular weight HA (LMW HA), and oligosaccharides (oHA). The intracellular signaling pathways initiated by HA interactions with CD44 and RHAMM that lead to inflammatory and tumorigenic responses are complex. Interestingly, these molecules have dual functions in inflammations and tumorigenesis. For example, the presence of CD44 is involved in initiation of arthritis, while the absence of CD44 by genetic deletion in an arthritis mouse model increases rather than decreases disease severity. Similar dual functions of CD44 exist in initiation and progression of cancer. RHAMM overexpression is most commonly linked to cancer progression, whereas loss of RHAMM is associated with malignant peripheral nerve sheath tumor growth. HA may similarly perform dual functions. An abundance of HMW HA can promote malignant cell proliferation and development of cancer, whereas antagonists to HA-CD44 signaling inhibit tumor cell growth in vitro and in vivo by interfering with HMWHA-CD44 interaction. This review describes the roles of HA interactions with CD44 and RHAMM in inflammatory responses and tumor development/progression, and how therapeutic strategies that block these key inflammatory/tumorigenic processes may be developed in rodent and human diseaseshttp://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00201/fullInflammationCancerCD44hyaluronanRHAMM
spellingShingle SUNITI eMISRA
Roger R. Markwald
Vincent C. Hascall
Shibnath eGhatak
INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
Frontiers in Immunology
Inflammation
Cancer
CD44
hyaluronan
RHAMM
title INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
title_full INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
title_fullStr INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
title_full_unstemmed INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
title_short INTERACTIONS BETWEEN HYALURONAN AND ITS RECEPTORS (CD44, RHAMM) REGULATE THE ACTIVITIES OF INFLAMMATION AND CANCER
title_sort interactions between hyaluronan and its receptors cd44 rhamm regulate the activities of inflammation and cancer
topic Inflammation
Cancer
CD44
hyaluronan
RHAMM
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00201/full
work_keys_str_mv AT sunitiemisra interactionsbetweenhyaluronananditsreceptorscd44rhammregulatetheactivitiesofinflammationandcancer
AT rogerrmarkwald interactionsbetweenhyaluronananditsreceptorscd44rhammregulatetheactivitiesofinflammationandcancer
AT vincentchascall interactionsbetweenhyaluronananditsreceptorscd44rhammregulatetheactivitiesofinflammationandcancer
AT shibnatheghatak interactionsbetweenhyaluronananditsreceptorscd44rhammregulatetheactivitiesofinflammationandcancer